CYCN
NASDAQ · Biotechnology
Cyclerion Therapeutics Inc
$1.47
+0.03 (+1.73%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,381.0% upside
Low Target
$14.42
Average Target
$21.77
High Target
$30.48
Current Price
$1.47
Current
$1.47
$1.47
Target
$21.77
$21.77
$14.42
$21.77 avg
$30.48
Scenario Analysis
Bear Case
$14.42
881.0%
Low target
Base Case
$21.77
+1,381.0%
Avg target
Bull Case
$30.48
+1,973.5%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$3.79
-61.2% from high
52-Week Low
$1.03
+43.2% from low
Target vs 52W High
$21.77
+474.4% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +18.4% |
| AMGN | Hold | 42 | 50% | $190.87 | -45.8% |
| GILD | Strong Buy | 38 | 79% | $362.68 | +160.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -1.8% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.1% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -69.1% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -12.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -28.5% |